Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

MDxHealth (MDXH) Net Income towards Common Stockholders: 2021-2025

Historic Net Income towards Common Stockholders for MDxHealth (MDXH) over the last 5 years, with Sep 2025 value amounting to -$8.0 million.

  • MDxHealth's Net Income towards Common Stockholders rose 23.68% to -$8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$31.1 million, marking a year-over-year increase of 24.70%. This contributed to the annual value of -$38.1 million for FY2024, which is 11.67% up from last year.
  • As of Q3 2025, MDxHealth's Net Income towards Common Stockholders stood at -$8.0 million, which was down 8.82% from -$7.4 million recorded in Q2 2025.
  • Over the past 5 years, MDxHealth's Net Income towards Common Stockholders peaked at -$6.7 million during Q4 2024, and registered a low of -$18.1 billion during Q2 2022.
  • For the 3-year period, MDxHealth's Net Income towards Common Stockholders averaged around -$9.5 million, with its median value being -$10.0 million (2023).
  • The largest annual percentage gain for MDxHealth's Net Income towards Common Stockholders in the last 5 years was 99.94% (2023), contrasted with its biggest fall of 41.58% (2023).
  • Over the past 5 years, MDxHealth's Net Income towards Common Stockholders (MRQ) stood at -$20.9 million in 2021, then skyrocketed by 41.77% to -$12.2 million in 2022, then grew by 12.02% to -$10.7 million in 2023, then skyrocketed by 37.07% to -$6.7 million in 2024, then dropped by 18.93% to -$8.0 million in 2025.
  • Its Net Income towards Common Stockholders was -$8.0 million in Q3 2025, compared to -$7.4 million in Q2 2025 and -$8.9 million in Q1 2025.